Skip to main content

Home/ healthcare regulation and scandals/ Group items tagged orders

Rss Feed Group items tagged

Brett Snodgrass

94 F.3d 652 - NOTICE: Ninth Circuit Rule 36-3 provides that dispositions other than opi... - 0 views

  • United States Court of Appeals, Ninth Circuit.
  • Mishler's original complaint alleged the malicious deprivation of his constitutionally-protected property right to obtain official verification of the existence of his license
  • licensing tribunal must be impartial and cannot act on the basis of personal bias.
  • ...1 more annotation...
  • Each party to bear its own costs. Both parties' requests for attorney's fees under 42 U.S.C. § 1988 are denied.
  •  
    It took 10 years of litigation to address the corruption and dishonesty of the state medical board. The state medical board members used the state's authority to pursue strictly personal agendas and they maliciously deprived Alan J. Mishler, MD, the good neurosurgeon of his constitutional rights. 
Brett Snodgrass

The Breast Cancer Charity Scam - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Scandal as cheap breast cancer prevention drug is 'left on the shelf' by NHS | UK | New... - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Risk of breast cancer among young women: relationship to induced abortion. - PubMed - NCBI - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Reform, Regulation, and Pharmaceuticals - The Kefauver-Harris Amendments at 50 - NEJM - 0 views

  • Kefauver–Harris Amendments
  • thalidomide scandal
  • state
  • ...12 more annotations...
  • 17 months of hearings
  • pharmaceutical executives
  • openly berated
  • profiteering
  • doctors were portrayed as dupes of pharmaceutical companies' marketing departments
  • FDA review claims of efficacy before drug approval
  • readable generic names
  • regulation of efficacy
  • American Medical Association
  • efficacy provision
  • (Frances Kelsey),
  • thalidomide
  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

reAGENRTS_2_Ar2_Img1_03_9d59be68e2.jpg (894×600) - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

ABIM Cheating Scandal: Take a Look at Some Test Questions - Health Blog - WSJ - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

JAMA Network | JAMA | Mishandling Misconduct: The NSABP Lumpectomy Trial - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

in-Training Medical Education (#MedEd) Forum * Medstro - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Risk factors for triple-negative breast cancer in women under the age of 45 years. - Pu... - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Rapid Progression of Basal-Type Breast Cancer - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Dr Social - Breast Cancer Fiasco Maybe only for ER PR - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Materials and Methods - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Results - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

H&R Block®-2013 Unallowed Expenses and Losses - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Mishler v. State Bd. of Med. Examiners, 849 P. 2d 291 - Nev: Supreme Court 1993 - Googl... - 0 views

  • Dr. Alan J. Mishler
  • After a brief association with the neurosurgeon in Reno, Dr. Mishler, appalled at the neurosurgeon's standards of practice and his billing procedures, refused to work with him any longer.
  • Dr. Mishler
  • ...32 more annotations...
  • the Chairman of the Department of Neurosurgery at Washoe Medical Center (WMC)
  • brought his concerns to the attention of
  • Governor
  • an investigator
  • he Board
  • the Board obstructed Dr. Mishler's access to the records.
  • WMC did not renew Dr. Mishler's hospital privileges.
  • As a result, Dr. Mishler could not obtain work elsewhere
  • Board denied him access to the evidence (X-rays and radiographs)
  • none of the experts had an opportunity to review the X-rays
  • When WMC initiated the hostile chart review against Dr. Mishler
  • First, the Board's timing is suspect because it initiated proceedings against Dr. Mishler five years after he treated the patients in question, when the Board knew that WMC had a five-year retention policy
  • According to the uncontroverted evidence, Dr. Mishler's colleagues, in retaliation against him for his candor
  • the Board's failure to retain the records relevant to the license revocation proceedings against Dr. Mishler demonstrates a significant degree of discovery abuse
  • Board knew that Dr. Mishler had declared bankruptcy and could not afford counse
  • Fifth, the merits of the allegations against Dr. Mishler were inadequately addressed because neither he nor any of the witnesses had the opportunity to view the X-rays and diagnostic films.
  • similar abuses
  • Dr. Mishler's surgeries were successful, the symptoms vanished,
  • The sole purpose of the power to revoke a physician's license is to protect the public.
  • Boswell held that a doctor's harsh criticism of other doctors did not warrant revocation of his license
  • the discipline was unwarranted.
  • The Board's power was not exercised for the proper and commendable purpose of protecting 297*297 the public from incompetent and negligent physician
  • Instead, the Board wielded its power to ruin the career of an outspoken physician while simultaneously protecting a possibly negligent or incompetent practitioner who had questionable billing procedures.
  • only one
  • subsequently found to be unjustified,
  • Board
  • limit the evidence
  • obstruct Dr. Mishler's access to evidence,
  • violated the same policy
  • The Board knew that Dr. Mishler was so impoverished that he had declared bankruptcy, and that he could ill afford to hire counse
  • In short, we conclude that the Board's actions and the proceedings against Dr. Mishler constituted a disturbing abuse of its power
  • reverse the disciplinary order of the Board in its entirety and dismiss all proceedings against Dr. Mishler with prejudice
  •  
    too painful to read. torture of physicans for reporting bad doctors.
1 - 20 of 24 Next ›
Showing 20 items per page